Fall 2017 Schedule

Student Journal Club presentations are held at noon on Wednesdays, in Biomed I, Room B300.

October 4, 2017 – Catheryn Wilson (Prather/Fantegrossi Laboratory)

http://jpet.aspetjournals.org/content/361/1/162

Thomas BF, Lefever TW, Cortes RA, Grabenauer M, Kovach AL, Cox AO, Patel PR, Pollard GT, Marusich JA, Kevin RC, Gamage TF and WIley JL. Thermolytic Degradation of Synthetic CAnnabinoids: Chemical Exposures and Pharmacological Consequences. Journal of Pharmacology and Experimental Therapeutics April 2017, 361(1)162-171.

October 11, 2017 – Two Presenters

Kyle Urquhart (Fantegrossi Laboratory)

http://bd4uz2kj6y.search.serialssolutions.com/OpenURL_local?sid=Entrez:PubMed&id=pmid:21921839

Altarifi AA, Negus SS. Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol. 2011 Oct;22(7):663-73.

Laura Ewing (Koturbash Laboratory)

https://link.springer.com/content/pdf/10.1007%2Fs00726-016-2318-9.pdf

Mazor KM, Stipanuk MH. GCN2- and elF2α-phosphorylation-independent, but ATF4-dependent, induction of CARE-containing genes in methionine-deficient cells. Amino Acids. 2016 Dec;48(12:2831-2842.

October 18, 2017 – Brittney Garner (Rusch Laboratory)

http://ajprenal.physiology.org/content/ajprenal/312/5/F861.full.pdf

Kneedler SC, Phillips LE, Hudson KR, Beckman KM, Lopez Gelston CA, Rutkowski JM, Parrish AR, Doris PA, Mitchelle BM. Renal inflammation and injury are associated with lymphangiogenesis in hypertension. Am J Physiol Renal Physiol. 2017 May 1:312(5):F861-F869.

October 25, 2017 – Christian Cabanlong (Prather Laboratory)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012889/

Read C, Fitzpatrick CM, Yang P, Kuc RE, Maguire JJ, Glen RC, Foster RE, Davenport AP. Cardiac action of the first G protein biased small molecule apelin agonist. Biochem Pharmacol. 2016 Sep 15:116-63-72.

November 1, 2017 – Chris Bolden (Peterson Laboratory)

http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2012.07864.x/epdf

Kelly KA, Miller DB, Bowyer JF, O’Callaghan JP. Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine. J Neurochem. 2012 Sep;122(5):995-1009.

November 8, 2017 – Stephen Shrum (MacMillan-Crow Laboratory)

https://www.ncbi.nlm.nih.gov/pubmed/28777255

Stowe DF, Yang M, Heisner JS, Camara AKS. Endogenous and agonist-induced opening of mitochondrial big vs. small Ca2+-sensitive K+ channels on cardiac cell and mitochondrial protection. J Cardiovasc Pharmacol. 2017 Aug 4 doi: 10.1097/FJC.0000000000000524.

November 15, 2017 – Samantha McClenahan (Owens Laboratory)

http://europepmc.org/articles/pmc4860013

Bremer PT, Kimishima A, Schlosburg JE, Zhou B, Collins KC, and Janda KD. Combatting synthetic designer opiods: active vaccination ablates lethal doses of fentanyl class drugs. Angew Chem Int Ed Engl. 2016 March 7; 55(11): 3772–3775.

November 29, 2017 – Michael Cozart (Zheng Laboratory)

http://www.sciencedirect.com/science/article/pii/S0306452216304432?via%3Dihubhttp://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2012.07864.x/epdf

Min SJ, Kang TC. Positive feedback role of TRPC3 in TNF-α-mediated vasogenic edema formation induced by status epilepticus independent of ETB receptor activation. Neuroscience. 2016 Nov 19:337:37-47

December 6, 2017 – Julia Tobacyk (MacMillan-Crow Laboratory)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806274/pdf/JCB_200906083.pdf

Head B, Griparic L, Amiri M, Gandre-Babbe S, van der Bliek AM. Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. J Cell Biol. 2009 Dec 28:187(7):959:66.